Efficacy of pneumococcal conjugate vaccine in children;Bedeutung der pneumokokken-impfung bei säuglingen und kleinkindern

Klinische Padiatrie

Volumn 213, Issue 3, 2001, Pages 109-113

  Adam, D ^a   Scholz, Horst ^b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b HELIOS KLINIKUM BERLIN BUCH   (Germany)

Author keywords

Meningitis; Otitis media; Pneumococci; Pneumonia; Vaccination

Indexed keywords

ANTIBIOTIC AGENT; MACROLIDE; PNEUMOCOCCUS VACCINE;

ANTIBIOTIC RESISTANCE; BACTERIAL INFECTION; GERMANY; HUMAN; MENINGITIS; MORTALITY; OTITIS MEDIA; PNEUMONIA; REVIEW; SEPSIS; SINUSITIS; STREPTOCOCCUS PNEUMONIAE; TREATMENT OUTCOME; VACCINATION; ARTICLE; BACTERIAL MENINGITIS; CLINICAL TRIAL; FEMALE; IMMUNIZATION; IMMUNOLOGY; INFANT; LOBAR PNEUMONIA; MALE; PRESCHOOL CHILD; STREPTOCOCCUS INFECTION;

CHILD, PRESCHOOL; CLINICAL TRIALS; FEMALE; GERMANY; HUMANS; IMMUNIZATION SCHEDULE; INFANT; MALE; MENINGITIS, PNEUMOCOCCAL; OTITIS MEDIA; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; PNEUMONIA, PNEUMOCOCCAL; SINUSITIS;

EID: 0034743935     PISSN: 03008630     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-15860     Document Type: Review

References (18)

1. 1 Adam D, Scholz H, Helmerking M. Short-course treatment of 4782 culture-proven cases of group A streptococcal tonsillopharyngitis and incidence of poststreptococcal sequelae. J Infect Dis 2000; 182: 509-516
2. 2 American Academy of Pediatrics, Committee on Infectious Diseases. Policy statement: Recommendations for the prevention of pneumococcal infections, including the use of pneumococcal conjugate vaccine (Prevnar), pneumococcal polysaccharide vaccine, and antibiotic prophylaxis. Pediatrics 2000; 106: 362-366
3. 3 American Academy of Pediatrics, Overturf GD and the Committee on Infectious Diseases. Technical report: Prevention of pneumococcal infections, including the use of pneumococcal conjugate and polysaccharide vaccines and antibiotic prophylaxis. Pediatrics 2000; 106: 367-376
4. 4 Black S, Shinfield H, Fireman B, Lewis E, Ray P, Hansen JR, Elvin L, Ensor KM, Hackell J, Siber G, Malinoski F, Madore D, Chang I, Kohberger R, Watson W, Austrian R, Edwards K, and the Northern California Kaiser Permanente Vaccine Study Center Group. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr Infect Dis J 2000; 19: 187-195
5. 5 Boken DJ, Chartrand SA, Moland ES, Goering RV. Colonization with penicillin-nonsusceptible streptococcus pneumoniae in urban and rural child-care centers. Pediatr Infect Dis J 1996; 15: 667-672
6. 6 Advisory Committee on Immunization Practices (ACIP). Preventing pneumococcal disease among infants and young children. Morb Mort Month Rep 2000; 49 RR-9: 1-35
7. 7 Craig AS, Erwin PC, Schaffner W, Elliott JA, Moore WL, Ussery XT, Patterson L, Dake AD, Hannah SG, Butler JC. Carriage of multi-drug-resistent streptococcus pneumoniae and impact of chemoprophylaxis during an outbreak of meningitis at a day care center. Clin Infect Dis 1999; 29: 1257-1264
8. 8 Eskola J. Immunogenicity of pneumococcal conjugate vaccines. Pediatr Infect Dis J 2000; 19: 388-393
9. 9 Eskola J, Kilpi T, Palmu A, Jokinen J, Haapakoski J, Herva E, Takala A, Käyhty H, Karma P, Kohberger R, Siber G, Mäkelä H for the Finnish Otitis Media Group. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. New Engl J Med 2001; 344: 403-409
10. 10 Givon-Lavi N, Dagan R, Fraser D, Yagupsky P, Porat N. Marked differences in pneumococcal carriage and resistance patterns between day care centers located within a small area. Clin Infect Dis 1999; 29: 1274-1280
11. 11 Nelson WL, Kuritzky JN, Kennedy DL. Outpatient pediatric antibiotic use in the US: trends and therapy for otitis media, 1977-1986. Abstract of the 27th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, DC 1987
12. 12 Kries R von, Siedler A, Schmitt HJ. Proportion of invasive pneumococcal infections in German children preventable by pneumococcal conjugate vaccines. Clin Infect Dis 2000; 31: 482-487
13. 13 Kries R von, Siedler A, Schmitt HJ. Epidemiologie von Pneumokokken-Infektionen bei Kindern. Kinderärtzl Prax 2000; 71: 435-438
14. 14 Levine OS, Farley M, Harrison LH, Lefkowitz L, MyGeer A, Schwartz B. Risk factors for invasive pneumococcal disease in children: a population-based case-control study in North America. Pediatrics 1999; 103: 1-5
15. 15 Reinert RR, Simic S, Laham A, Reinert S, Lemperle M, Lütticken R. Antimicrobial resistence of streptococcus pneumoniae recovered from outpatients with respiratory tract infections in Germany, 1998-1999: Results of a national surveillance study. J Clin Microbiol 2001; 39: in press
16. 16 Robert Koch Institut. Teil 4: Infektionen des Zentralnervensystems - 2. Folge. Andere bakterielle Meningitiden. Epidemiol Bull 2000; Nr. 36: 287-289
17. 17 Takala AK, Gero J, Kela E, Ronnberg PR, Koskenniemi E, Eskola J. Risk factors for primary invasive pneumococcal disease among children in Finland. JAMA 1995; 273: 859-864
18. 18 Yagupsky P, Porat N, Fraser D, Prajgrod F, Merires M, McGee L, Klugman KP, Dagan R. Acqusition, carriage, and transmission of pneumococci with decreased antibiotic susceptibility in young children attending a day care facility in southern Israel. J Infect Dis 1998; 177: 1003-1012